Viewing StudyNCT00045396



Ignite Creation Date: 2024-05-05 @ 11:26 AM
Last Modification Date: 2024-10-26 @ 9:07 AM
Study NCT ID: NCT00045396
Status: COMPLETED
Last Update Posted: 2013-01-09
First Post: 2002-09-06

Brief Title: A Phase II Study Of The Farnesyltransferase Inhibitor ZANESTRA R115777 NSC 702818 IND 58359 In Complete Remission Following Induction AndOr Consolidation Chemotherapy In Adults With Poor-Risk Acute Myelogenous Leukemia AML And High-Risk Myelodysplasia MDS
Sponsor:
Organization: National Cancer Institute NCI